What is Cogent Biosciences, Inc.'s loss on debt extinguishment?

Cogent Biosciences, Inc. (COGT) reported loss on debt extinguishment of -$1.8M in Q4 2025.

What does loss on debt extinguishment mean?

Non-cash loss from retiring debt before maturity, added back in operating cash flow since the cash impact is in financing.

Cogent Biosciences, Inc. COGT Loss on Debt Extinguishment

Loss on Debt Extinguishment at other companies

Scholar RockSRRK

-$3.34M—

BridgeBio PharmaBBIO

$0+100%

Roivant SciencesROIV

$0+100%

TG TherapeuticsTGTX

-$9.15M—

Other financials

Income statement

See full

Operating income-$103.6M-38.3%

Net income-$97.4M-35.2%

EPS (diluted)-$0.53-1.9%

Balance sheet

See full

Cash & equivalents$241.2M+91.4%

Total debt$15.5M-9.4%

Total equity$607.7M+177%

Total assets$903.0M+218%

Cash flow

See full

Operating cash flow-$86.9M-30.6%

CapEx$449.0K-17.9%

Free cash flow-$87.3M-30.2%

Valuation

See full

Market cap$5.9B+816%

Enterprise value$5.68B+951%

P/S749.8×—

Profitability

See full

Operating margin-1,044.3%—

Net margin-950.4%—

FCF margin-184.7%—

Returns & leverage

See full

Return on equity-85.7%+1.7pp

Debt / equity0×-0.1×

Current ratio15.1×+10.0×

Where this comes from

Reported directly by Cogent Biosciences, Inc. in its filing.

Tagged under the XBRL concept us-gaap:GainsLossesOnExtinguishmentOfDebt.

The official record: Cogent Biosciences, Inc.’s 10-K, filed February 17, 2026, on SEC EDGAR. View the filing →

Ask your AI about Cogent Biosciences, Inc.'s loss on debt extinguishment.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Cogent Biosciences, Inc.'s loss on debt extinguishment?: Cogent Biosciences, Inc. (COGT) reported loss on debt extinguishment of -$1.8M in Q4 2025.
What does loss on debt extinguishment mean?: Non-cash loss from retiring debt before maturity, added back in operating cash flow since the cash impact is in financing.